drugset / Trial / NCT00495313

Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens

NCT00495313

Phase 4 Completed 91 enrolled CollaGenex Pharmaceuticals
RandomizedParallel-groupDouble-blindSupportive care

Summary

To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%

Timeline

Start
2007-03
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject COL-101 Unknown
Comparator Doxycycline Small molecule 40 mg
Comparator Doxycycline Small molecule 100 mg
Background Metronidazole Small molecule 1 % Topical

Indications